CALLAN JMB INC (CJMB)
NASDAQIndustrialsIntegrated Freight & LogisticsSnapshot 2026-09-04
$2.110.00%
Close 2026-09-04 · 1-day change
NASDAQIndustrialsIntegrated Freight & LogisticsSnapshot 2026-09-04
Warn: Management is running behind on a stated commitment.
Callan JMB is working to fix its Nasdaq listing problems and improve its operating income. The company has a $1.05 million public sector contract that helps revenue. It is raising up to $5 million through stock sales to support its cash needs.
The company is losing money and has not fixed its cash flow problems. It faces Nasdaq delisting risks and executive departures. The recent 7.5% one-day stock drop shows weak investor confidence.
The market prices in a steep decline in growth and ongoing losses, with the stock down 42% from its high and trading 68% below consensus price targets. Our fair value is $2.53, reflecting a cheap valuation versus peers but high risk.
Breaks if: Fail to raise $5M equity by 2026-Q3
Access capital markets via equity sales agreements to strengthen financial position and support operations.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround opportunity. CJMB is currently navigating through a period of volatility and loss-making, with management focused on improving operating income and cash flow.
The market seems to be pricing in a low fragility tier despite CJMB's expensive valuation compared to peers. There is a divergence driven by re-rating, indicating that investors may have high expectations for recovery.
Fundamentals are likely to improve gradually, as management has shown progress in reducing operating losses and cash burn. However, recent financial performance remains weak compared to industry peers, which could hinder momentum.
The thesis hinges on external factors such as the performance of sector bellwethers like UPS and FDX, which could influence the broader Industrials sector. Additionally, inflation trends and regulatory compliance with Nasdaq are critical for future performance.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The company is set to raise capital through equity sales. This acquisition enhances its potential for capital generation. There are no new threats impacting the thesis at this time.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 2 of last 2 quarters. The company executed equity sales agreements in 2026-Q1 and 2026-Q2 to raise up to $5 million. This capital raising effort aligns with management's stated goal to strengthen financial resources.
“Entered into At-The-Market Issuance Sales Agreement for up to $5 million.”
“Entered into Common Stock Purchase Agreement with Hexstone Capital.”
Breaks if: Cash flow remains negative beyond 2027-Q2
Improve cash flow from operating activities to reduce negative cash burn and strengthen liquidity.
Stated as a priority in 6 of last 6 quarters. Cash from operations improved from -$1.76 million in 2025-Q3 to -$396,063 in 2026-Q2, indicating progress in reducing cash burn. Management's repeated focus on enhancing cash flow is showing measurable improvement.
“Cash from operations was negative $396,063, efforts to improve cash flow ongoing.”
“Cash from operations was negative $1.68 million, focus on cash flow improvement.”
“Cash from operations was negative $659,000, management targeting better cash flow.”
“Cash from operations was negative $1.76 million, cash burn remains a concern.”
“Cash from operations was negative $563,272, efforts to reduce cash burn ongoing.”
“Cash from operations was negative $1.56 million, liquidity focus continues.”
Breaks if: Nasdaq delisting or failure to cure deficiencies by 2026-Q3
Resolve Nasdaq listing deficiencies related to minimum bid price and stockholders' equity to maintain listing status.
Stated as a priority in 2 of last 2 quarters. The company received Nasdaq deficiency notices in 2026-Q1 and 2026-Q2 for failing to meet minimum bid price and stockholders' equity requirements. The trajectory shows ongoing regulatory challenges with no resolution yet.
“Received notice from Nasdaq for failure to maintain minimum bid price.”
“Received deficiency letter from Nasdaq for not meeting stockholders' equity requirement.”
Breaks if: Operating loss remains worse than -$1.7M beyond 2026-Q4
Focus on reducing operating losses and improving operating income performance over multiple quarters.
Stated as a priority in 6 of last 6 quarters. Operating income losses improved from -$2.51 million in 2025-Q4 to -$1.35 million in 2026-Q2, showing a positive trend. Management's focus on improving operating income is delivering measurable progress.
“Operating income was negative $1.35 million, focus remains on improvement.”
“Operating income loss narrowed to $1.70 million from prior quarters.”
“Operating income loss was $2.51 million, efforts to reduce losses ongoing.”
“Operating income loss was $1.88 million, management targeting improvement.”
“Operating income loss was $1.41 million, focus on cost control.”
“Operating income loss was $1.24 million, improvement initiatives underway.”
Over the next 1 to 3 years, CJMB's trajectory will depend on management's ability to address operational challenges and external market conditions. Not investment advice.